优途加速器官方

优途加速器官方

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

优途加速器官方

Learn More
Folded page of a newspaper

优途加速器官方

优途加速器官方

Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results

优途加速器官方

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

优途加速器官方

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

优途加速器官方

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

优途加速器官方

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

优途加速器官方

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

叉叉加速器纯加速版ios  极光加速器官网下载地址  mielink羊圈使用教程  secure Ⅴpn apk  如何网上挂梯  免费加速器ios  暴雪vbn加速器